Brian C. Evanko's most recent trade in TriNet Group Inc was a trade of 2,649 Common Stock done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TriNet Group Inc | Brian C. Evanko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 2,649 | 4,565 (0%) | 0% | 0 | Common Stock | |
| Cigna Group | Brian C. Evanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 19,158 | 19,158 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 12,254 | 53,188 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 305.86 per share. | 28 Feb 2025 | 5,679 | 51,182 (0%) | 0% | 305.9 | 1,736,979 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 5,395 | 58,583 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 305.86 per share. | 28 Feb 2025 | 1,722 | 56,861 (0%) | 0% | 305.9 | 526,691 | Common Stock, $.01 Par Value |
| TriNet Group Inc | Brian C. Evanko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 1,916 | 1,916 (0%) | 0% | 0 | Common Stock | |
| Cigna Group | Brian C. Evanko | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.90 per share. | 24 Jun 2024 | 4,795 | 44,718 (0%) | 0% | 120.9 | 579,692 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 4,795 | 1,011 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | See Remarks | Sale of securities on an exchange or to another person at price $ 345.01 per share. | 24 Jun 2024 | 4,795 | 39,923 (0%) | 0% | 345.0 | 1,654,303 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.90 per share. | 24 Jun 2024 | 1,011 | 40,934 (0%) | 0% | 120.9 | 122,225 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 1,011 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 8,329 | 45,358 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 333.36 per share. | 01 Mar 2024 | 3,860 | 39,923 (0%) | 0% | 333.4 | 1,286,770 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 333.36 per share. | 01 Mar 2024 | 1,575 | 43,783 (0%) | 0% | 333.4 | 525,042 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 18,677 | 18,677 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 5,127 | 37,029 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 02 Aug 2023 | 2,307 | 31,332 (0%) | 0% | 300 | 692,100 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 2,307 | 570 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.04 per share. | 02 Aug 2023 | 2,307 | 33,639 (0%) | 0% | 78.0 | 180,027 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 570 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.04 per share. | 02 Aug 2023 | 570 | 31,902 (0%) | 0% | 78.0 | 44,480 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.44 per share. | 01 Mar 2023 | 1,342 | 31,332 (0%) | 0% | 289.4 | 388,428 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 6,759 | 35,814 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.27 per share. | 24 Feb 2023 | 2,792 | 32,674 (0%) | 0% | 294.3 | 821,602 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.27 per share. | 24 Feb 2023 | 348 | 35,466 (0%) | 0% | 294.3 | 102,406 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 16,268 | 16,268 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 4,403 | 29,055 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.48 per share. | 01 Mar 2022 | 607 | 24,652 (0%) | 0% | 236.5 | 143,543 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 2,447 | 26,625 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 229.64 per share. | 25 Feb 2022 | 767 | 25,259 (0%) | 0% | 229.6 | 176,134 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 229.64 per share. | 25 Feb 2022 | 599 | 26,026 (0%) | 0% | 229.6 | 137,554 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 21,297 | 21,297 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 4,750 | 24,178 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 2,053 | 20,673 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.31 per share. | 26 Feb 2021 | 644 | 19,428 (0%) | 0% | 210.3 | 135,440 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.31 per share. | 26 Feb 2021 | 601 | 20,072 (0%) | 0% | 210.3 | 126,396 | Common Stock, $.01 Par Value |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 18,736 | 18,736 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | Brian C. Evanko | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 3,929 | 18,620 (0%) | 0% | 0 | Common Stock, $.01 Par Value |